Literature DB >> 3896737

Temocillin treatment of gynaecological infections with special reference to blood and tissue concentrations.

E R Weissenbacher, K Gutschow, A Bauernfeind, H G Luehr.   

Abstract

Tissue concentrations of temocillin were determined in samples from gynaecological surgical patients. Measurable concentrations of temocillin were observed during the entire time period investigated (up to 7 hours post administration). Inhibitory concentrations for the majority of susceptible bacteria were achieved. The therapeutic results observed in 40 patients with various infections (90% fully effective, 5% partially effective) confirm the high efficacy of temocillin in the treatment of gynaecological infections.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3896737     DOI: 10.2165/00003495-198500295-00038

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  3 in total

1.  Temocillin, in-vitro activity and the pharmacokinetics and tissue penetration in healthy volunteers.

Authors:  R M Brown; R Wise; J M Andrews
Journal:  J Antimicrob Chemother       Date:  1982-10       Impact factor: 5.790

2.  BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humans.

Authors:  B Slocombe; M J Basker; P H Bentley; J P Clayton; M Cole; K R Comber; R A Dixon; R A Edmondson; D Jackson; D J Merrikin; R Sutherland
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

3.  [Microbiological studies with the new penicillin BRL 17421 (temocillin)].

Authors:  R Malottke; J Potel
Journal:  Infection       Date:  1983 Jan-Feb       Impact factor: 3.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.